Kallikrein-15 Protein, Human (HEK293, Fc)

Kallikrein-15 is a kallikrein (KLK) with trypsin-like activity that may promote cancer metastasis. The study found that Kallikrein-15 is only strongly expressed in mature sperm cells and not in immature germ cells. KLK15 may be able to cleave many extracellular matrix (ECM) components, interact with the extracellular matrix (ECM) receptor group, and be associated with tumorigenesis. Kallikrein-15 Protein, Human (HEK293, Fc) is the recombinant human-derived Kallikrein-15 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of Kallikrein-15 Protein, Human (HEK293, Fc) is 240 a.a., with molecular weight of ~53.1 KDa.

Kallikrein-15 (KLK15) is a kallikrein (KLK). Previous research has suggested that KLK15 may play a role in prostate cancer. Chemical analysis of immunohistology of testes showed that KLK15 is strongly expressed in mature sperm cells but not in immature germ cells. The subcellular localization of KLK15 in the basal cell layer of the prostate epithelium is primarily in the nucleus. KLK15 also has trypsin-like activity and preferentially cleaves after arginine (R). KLK15 may be able to cleave many extracellular matrix (ECM) components, functionally similar to some KLK family members. The enzymatic activity of KLK15 is regulated by different factors such as pH, cations, and serine protease inhibitors. Notably, KLK15 is most likely associated with tumorigenesis by interacting with the extracellular matrix (ECM) receptor group and may promote metastasis through this mechanism.

Human

HEK293

C-hFc

Q9H2R5/NP_059979.2 (Q17-N256)

55554  [NCBI]

Approximately 53.1 kDa.

Greater than 80% as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.